Loading clinical trials...
Loading clinical trials...
A Phase 2a, Multicenter, Open-Label Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy
Conditions
Interventions
RVT-1401
Locations
4
Canada
UBC/VGH Eye Care Center
Vancouver, British Columbia, Canada
Toronto Retina Institute
North York, Ontario, Canada
University of Ottwa Eye Institute
Ottawa, Ontario, Canada
CIUSSS de I'Est-de-I'lle-de-Montreal, Installation Maisonneuve- Rosemont
Montreal, Quebec, Canada
Start Date
April 22, 2019
Primary Completion Date
February 29, 2020
Completion Date
May 21, 2020
Last Updated
January 24, 2022
NCT02535975
NCT00430547
NCT00174057
Lead Sponsor
Immunovant Sciences GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions